A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small cell lung cancer with wild-type EGFR: The Okayama Lung Cancer Study Group Trial 1202 (OLCSG1202)

被引：0
|
作者：
Bessho, A. [1 ]
Ochi, N. [2 ]
Kuyama, S. [3 ]
Umeno, T. [1 ]
Ikeda, G. [4 ]
Harada, D. [5 ]
Nogami, N. [5 ]
Ninomiya, K. [6 ]
Kishino, D. [7 ]
Chikamori, K. [8 ]
Fujimoto, N. [9 ]
Hotta, K. [10 ]
Takigawa, N. [2 ]
Kiura, K. [11 ]
机构：
[1] Japanese Red Cross Okayama Hosp, Resp Med, Okayama, Japan
[2] Kawasaki Med Sch, Gen Internal Med 4, Okayama, Japan
[3] Iwakuni Clin Ctr, Resp Med, Iwakuni, Japan
[4] Chugoku Cent Hosp, Resp Med, Fukuyama, Hiroshima, Japan
[5] Shikoku Canc Ctr, Resp Med, Matsuyama, Ehime, Japan
[6] Okayama Unvers Hosp, Resp Med, Okayama, Japan
[7] Japanese Red Cross Himeji Hosp, Resp Med, Himeji, Hyogo, Japan
[8] Yamaguchi Ube Med Ctr, Med Oncol, Ube, Yamaguchi, Japan
[9] Okayama Rosai Hosp, Med Oncol, Okayama, Japan
[10] Okayama Univ Hosp, Innovat Clin Med, Okayama, Japan
[11] Okayama Univ Hosp, Resp Med, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
455P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small cell lung cancer with wild type EGFR (OLCSG1202)
    Bessho, Akihiro
    Ochi, Nobuaki
    Kuyama, Shoichi
    Fujimoto, Nobukazu
    Umeno, Takahiro
    Ninomiya, Kiichiro
    Ikeda, Genyo
    Harada, Daijiro
    Kishino, Daizo
    Hosokawa, Shinobu
    Chikamori, Kenichi
    Nogami, Naoyuki
    Harita, Shingo
    Ueoka, Hiroshi
    Hotta, Katsuyuki
    Takigawa, Nagio
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202
    Kuyama, Shoichi
    Ochi, Nobuaki
    Bessho, Akihiro
    Hotta, Katsuyuki
    Ikeda, Genyo
    Kishino, Daizo
    Kubo, Toshio
    Harada, Daijiro
    Fujimoto, Nobukazu
    Nakanishi, Masamoto
    Umeno, Takahiro
    Okada, Toshiaki
    Chikamori, Kenichi
    Yamagishi, Tomoko
    Ohashi, Kadoaki
    Ichihara, Eiki
    Takigawa, Nagio
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. LUNG CANCER, 2017, 112 : 188 - 194
  • [3] A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer Cancer
    Minemura H.
    Yokouchi H.
    Azuma K.
    Hirai K.-I.
    Sekine S.
    Oshima K.
    Kanazawa K.
    Tanino Y.
    Inokoshi Y.
    Ishii T.
    Katsuura Y.
    Oishi A.
    Ishida T.
    Munakata M.
    [J]. BMC Research Notes, 8 (1)
  • [4] Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)
    Miyanaga, Akihiko
    Kubota, Kaoru
    Hosomi, Yukio
    Okuma, Yusuke
    Minato, Koichi
    Fujimoto, Sakae
    Okamoto, Hiroaki
    Satouchi, Miyako
    Isobe, Hiroshi
    Aono, Hiromi
    Takiguchi, Yuichi
    Gemma, Akihiko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (08) : 749 - 754
  • [5] Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer
    Tamura, Kenji
    Okamoto, Isamu
    Ozaki, Tomohiro
    Kashii, Tatsuhiko
    Takeda, Koji
    Kobayashi, Masashi
    Matsui, Kaoru
    Shibata, Takashi
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    Fukuoka, Masahiro
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) : 2132 - 2137
  • [6] Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)
    Kubota, K.
    Miyanaga, A.
    Hosomi, Y.
    Okuma, Y.
    Minato, K.
    Fujimoto, S.
    Takiguchi, Y.
    Okamoto, H.
    Hattori, Y.
    Isobe, H.
    Aono, H.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [7] A Phase II Study of S-1 and Thoracic Irradiation for Elderly Pts with Locally Advanced Non-Small Cell Lung Cancer: Okayama Lung Cancer Study Group
    Ueoka, Hiroshi
    Hotta, Katsuyuki
    Takigawa, Nagio
    Maeda, Tadashi
    Aoe, Keisuke
    Chikamori, Kenichi
    Kishino, Daizo
    Nogami, Naoyuki
    Harita, Shingo
    Hosokawa, Shinobu
    Gemba, Kenichi
    Fujiwara, Keiichi
    Fujiwara, Yoshiro
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S570 - S570
  • [8] A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer
    Takashi Kobayashi
    Tomonobu Koizumi
    Toshihide Agatsuma
    Masanori Yasuo
    Kenji Tsushima
    Keishi Kubo
    Seiichiro Eda
    Hiroshi Kuraishi
    Shigeru Koyama
    Tsutomu Hachiya
    Nariaki Ohura
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 1241 - 1246
  • [9] A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Agatsuma, Toshihide
    Yasuo, Masanori
    Tsushima, Kenji
    Kubo, Keishi
    Eda, Seiichiro
    Kuraishi, Hiroshi
    Koyama, Shigeru
    Hachiya, Tsutomu
    Ohura, Nariaki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1241 - 1246
  • [10] Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Yanagitani, Noriko
    Imai, Hisao
    Utsugi, Mitsuyoshi
    Iwasaki, Yasuki
    Shimizu, Kimihiro
    Iijima, Hironobu
    Tsurumaki, Hiroaki
    Tornizawa, Yoshio
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Saito, Ryusei
    Mori, Masatomo
    [J]. LUNG CANCER, 2010, 68 (02) : 253 - 257
12345